Middle East respiratory syndrome coronavirus: MERS-CoV treatment effective in monkeys
Sunday, September 8, 2013 - 13:30
in Health & Medicine
Scientists report that a combination of two licensed antiviral drugs reduces virus replication and improves clinical outcome in a recently developed monkey model of Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Their study expands on recent work showing that a combination of ribavirin and interferon-alpha 2b stops MERS-CoV from replicating in cell culture.